



Neonatal morbidity after induction vs expectant monitoring
in intrauterine growth restriction at term:
a subanalysis of the DIGITAT RCT
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Maria G. van Pampus, MD, PhD; Marc E. A. Spaanderdam, MD, PhD; Johannes J. Duvekot, MD, PhD;
Henk A. Bremer, MD, PhD; Friso M. C. Delemarre, MD, PhD; Kitty W. M. Bloemenkamp, MD, PhD;
Christianne J. M. de Groot, MD, PhD; Christine Willekes, MD, PhD; Monique Rijken, MD, PhD;
Frans J. M. E. Roumen, MD, PhD; Jim G. Thornton, MD, FRCOG; Jan M. M. van Lith, MD, PhD;
BenW. J. Mol, MD, PhD; Saskia le Cessie, PhD; Sicco A. Scherjon, MD, PhD; for the DIGITAT Study GroupOBJECTIVE: The Disproportionate Intrauterine Growth Intervention Trial
at Term (DIGITAT) compared induction of labor and expectant manage-
ment in suspected intrauterine growth restriction (IUGR) at term. In this
subanalysis, we report neonatal morbidity between the policies based
on the Morbidity Assessment Index for Newborns (MAIN).
STUDY DESIGN: We used data from the DIGITAT. For each neonate, we
alculated the MAIN score, a validated outcome scale.
RESULTS: There were no differences in mean MAIN scores or in MAIN
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344.e1 American Journal of Obstetrics& Gynecology APRIL 2012CONCLUSION: The incidence of neonatal morbidity in IUGR at term is
comparable and relatively mild either after induction or after an expect-
ant policy. However, neonatal admissions are lower after 38 weeks of
pregnancy, so if induction to preempt possible stillbirth is considered, it
is reasonable to delay until 38 weeks, provided watchful monitoring.
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eIntrauterine growth restriction (IUGR)isdefinedas anestimated fetalweightor
an abdominal circumference below the
10th centile for gestational age.1 Postna-
ally, childrenwith abirthweight below the
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2.01.015term. There is no consensus on the man-
agement of pregnancies complicated by
IUGR.14-16
We recently performed the Dispro-
portionate Intrauterine Growth Inter-
vention Trial at Term (DIGITAT)17 to
nvestigate whether induction of labor
or pregnancies with suspected IUGR
eyond 36weeks’ gestation reduced neo-
atal morbidity andmortality compared
ith an expectant approach with fetal
nd maternal surveillance. Unlike many
etrospective studies on growth restric-
ion, our study did not look retrospec-
ively at childrenbeingborn SGAbut fol-
owed up children prospectively with
uspected IUGR at term.
The study showed comparable primary
etal outcomes (a composite of perinatal
eath, 5 minute Apgar score below 7, um-
ilical arterial pHbelow7.05, or admission
o neonatal intensive care unit [NICU]) as
ell as comparable rates of operativedeliv-





































www.AJOG.org Obstetrics Researchnot differ between the groups, more chil-
dren in the inductiongroupwereadmitted
to an intermediate level of care than in
the expectant group (48% vs 36%; dif-
ference, 12%; 95% confidence interval
[CI], 5–20%).
Complications of late prematurity13,18,19
might explain this because children in the
induction group were born on average 10
days earlier than in the expectant group,
(266daysvs277days;difference,–9.9days;
95%CI, –11 to –9).17 However, the differ-
ncemay simply reflect policies for admis-
ionto intermediate levelsof care related to
rematurity rather than clinically relevant
orbidity.
It is important to resolve these 2 com-
eting explanations because in the ex-
ectant group, more children were se-
erely growth restricted, defined as a
irthweight below the third percentile
13% vs 31%: difference, –18%; 95%CI,
24% to –12%) and therefore had a
ossible higher risk of neonatal morbid-
ty.2-4,6-12 To study the net influence of
he 2 policies on neonatal morbidity in
etail, the Morbidity Assessment Index
or Newborns (MAIN) score, a validated
utcome measure for neonatal morbid-
ty, was calculated and compared.20,21
MATERIALS AND METHODS
This is a secondary analysis of the DIGI-
TAT. The original trial was approved by
the University of Leiden Institutional
Review Board (P04.210). Written in-
formed consent was obtained from all
participants before randomization.
The study population consisted of
children born to mothers who partici-
pated in theDIGITAT. BetweenNovem-
ber 2004 and November 2008, pregnant
women with a singleton fetus in cephalic
presentation and suspected IUGR be-
tween 360 and 410 weeks were re-
cruited. Suspected IUGR was defined as
a fetal abdominal circumference or an
estimated fetal weight below the 10th
percentile or deceleration of the fetal ab-
dominal circumference in the third
trimester.20
Exclusion criteria were previous cesar-
ean section, diabetes mellitus, or gesta-
tional diabetes requiring insulin therapy,
renal failure, human immunodeficiencyvirus seropositivity, prelabor rupture of
membranes, severe preeclampsia, HELLP
syndrome (hemolysis, elevated liver en-
zymes, and low platelet count), or a fetus
with aneuploidy or congenital abnormali-
ties suspected on ultrasound. Fetuses with
decreasedor absentmovements, and those
with abnormal heart rate tracings, were
also excluded.
Consentingwomenwere randomly al-
located to either induction or expectant
monitoring. Participants allocated to the
expectant monitoring group were mon-
itored until the onset of spontaneous la-
bor with daily fetal movement counts
and twice-weekly heart rate tracings, ul-
trasound examination, maternal blood
pressure measurement, assessment of
proteinuria, laboratory tests of liver and
kidney function, and full blood count.
Women were monitored as either an
outpatient or an inpatient, according to
local protocol. In the expectantmonitor-
ing group, induction of labor or planned
cesarean section was performed for ob-
stetrical indications, such as suboptimal
fetal heart rate tracings, prolonged rup-
ture of membranes, or postmaturity be-
tween T plus 7 and T plus 14 days, at the
obstetrician’s discretion.
Morbidity was calculated using the
MAIN score.20,21 This score was devel-
oped to provide a numeric index of early
neonatal outcomes of prenatal care and
adverse prenatal exposures in babies de-
livered beyond 28weeks of gestation. It is
a sensitive and discriminative outcome
FIGURE 1
Flow diagram of study subjects an
oers. Neonatal morbidity in the disproportionate intrauterinmeasure for obstetric clinical trials and is m
APRIL 2012 Americparticularly suited for studies with out-
comes other than extremepretermdeliv-
ery. The data items, such as Apgar scores
at 5 and 10 minutes, cord blood pH, hy-
perbilirubinemia, hypoglycemia, intra-
ventricular hemorrhage, and the need
for intubation, can all be obtained from
the hospital discharge summaries. The
final score is divided into 4 morbidity
categories: below 150 (no/minimal mor-
bidity), 151-500 (mild morbidity), 501-
800 (moderate morbidity), and more
than 800 (severe morbidity).21
A MAIN score greater than zero is
considered as a positiveMAIN score. For
children admitted to the NICU or inter-
mediate level care, items for the MAIN
score were obtained from the discharge
summaries. For those discharged home
immediately after birth or admitted only
to the maternal ward, no separate dis-
charge summaries are written, so for
them 5 and 10 minute Apgar scores and
arterial umbilical artery pH only were
used, assuming that the other items, if
not reported, were normal.
Data were analyzed according to in-
tention to treat. Continuous variables
were compared using a Student t test or
Fisher exact test when data were nor-
mally distributed or the nonparametric
Mann-Whitney U test for skewed data.
he 2 test was used for categorical vari-
bles. Treatment effects were presented
s difference in percentages with 95%
Is. P values less than .05 were consid-
red to indicate statistical significance. If
eir admission categories
owth intervention trial at term. Am J Obstet Gynecol 2012.d th
B e grore than 5% of observations were
an Journal of Obstetrics& Gynecology 344.e2
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or mean (95% CI)
Nulliparous 182 (56.7) 201 (61.1) 4.4 (12.0 to 3.2)
................................................................................................................................................................................................................................................................................................................................................................................
Maternal age, y 26.9 (23.3–31.2) 27.4 (23.3–31.4) 0.04 (8.6 to 7.8)
................................................................................................................................................................................................................................................................................................................................................................................
BMI at study entrya 21.9 (19.7–25.5) 22.2 (19.7–25.6) 0.1 (1.0 to 0.7)
................................................................................................................................................................................................................................................................................................................................................................................
Maternal smokingb 138 (46.9) 127 (40.8) 6.1 (1.8 to 14)
................................................................................................................................................................................................................................................................................................................................................................................
Gestational age at randomization, d 264 (258–269) 264 (258–268) 0.7 (2.1 to 0.7)
................................................................................................................................................................................................................................................................................................................................................................................




Lower professional school 168 (52.3) 170 (51.7) 0.6 (7.0 to 8.4)
.......................................................................................................................................................................................................................................................................................................................................................................
Medium professional school 26 (8.1) 37 (11.2) 3.1 (7.7 to 1.4)
.......................................................................................................................................................................................................................................................................................................................................................................




Fetal abdominal circumference less than the 10th percentile 262 (81.6) 270 (82.1) 0.5 (6.4 to 5.5)
.......................................................................................................................................................................................................................................................................................................................................................................
Estimated fetal weight less than the 10th percentile 296 (92.2) 308 (93.6) 1.4 (5.4 to 2.5)
.......................................................................................................................................................................................................................................................................................................................................................................




Spontaneous 12 (3.7) 151 (46.0) 42.3 (48.1 to 36.5)
.......................................................................................................................................................................................................................................................................................................................................................................
Induction 306 (95.6) 166 (50.6) 45.0 (39.2–50.9)
.......................................................................................................................................................................................................................................................................................................................................................................




Spontaneous 249 (77.6) 257 (78.1) 0.5 (6.9 to 5.8)
.......................................................................................................................................................................................................................................................................................................................................................................
Vaginal instrumental 27 (8.4) 27 (8.2) 0.2 (4.0 to 4.4)
.......................................................................................................................................................................................................................................................................................................................................................................
Cesarean section 45 (14.0) 45 (13.7) 0.3 (5.0 to 5.6)
................................................................................................................................................................................................................................................................................................................................................................................
Time between randomization and onset of labor, d 0.9 (0.7–1.7) 10.4 (5.6–16.0) 9.6 (10.8 to 8.5)d
................................................................................................................................................................................................................................................................................................................................................................................
Gestational age at birth, d 266 (261–271) 277 (269–283) 9.9 (11.3 to 8.6)d
................................................................................................................................................................................................................................................................................................................................................................................




Less than third percentile 40 (12.5) 100 (30.6) 18.1 (24.3 to 12.0)d
.......................................................................................................................................................................................................................................................................................................................................................................
Third to fifth percentile 82 (25.5) 79 (24.2) 1.3 (5.3 to 8.0)
.......................................................................................................................................................................................................................................................................................................................................................................
Fifth to 10th percentile 88 (27.5) 62 (18.9) 8.5 (2.0 to 14.9)
.......................................................................................................................................................................................................................................................................................................................................................................
10th to 25th percentile 88 (27.4) 66 (20.2) 7.2 (0.713.8)
.......................................................................................................................................................................................................................................................................................................................................................................
Greater than 25th percentile 23 (7.2) 20 (6.1) 1.1 (2.8 to 4.9)
................................................................................................................................................................................................................................................................................................................................................................................




Intensive care 9 (2.8) 13 (4.0) 1.2 (4 to 1.6)
.......................................................................................................................................................................................................................................................................................................................................................................
Intermediate care 155 (48.3) 118 (35.9) 12.4 (4.9–20.0)e
.......................................................................................................................................................................................................................................................................................................................................................................
Maternal ward 89 (27.8) 116 (35.7) 7.9 (15 to 0.7)e
.......................................................................................................................................................................................................................................................................................................................................................................
No admission 67 (20.9) 78 (24.0) 3.1 (9.5–3.4)
................................................................................................................................................................................................................................................................................................................................................................................
Data were analyzed with the Student t test or 2 test. The table shows median (interquartile range 25th to 75th percentile or number [percentage]).
BMI, body mass index; CI, confidence interval.
a n 275 for induction; n 295 for expectant monitoring; b n 294 for induction; n 311 for expectant monitoring; c n 304 for induction; n 312 for expectant monitoring; d P .001;
e P .05.Boers. Neonatal morbidity in the disproportionate intrauterine growth intervention trial at term. Am J Obstet Gynecol 2012.
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terin 2.
www.AJOG.org Obstetrics Researchmissing, this was indicated in the foot-
note of the table. The scores for the in-
duction and expectant groupswere com-
pared for all babies and stratified by
gestational age at time of randomization
and for the different admission types.
We studied the effect of gestational age
at randomization on different outcome
parameters, such asmeanMAIN score, se-
vere MAIN score, and composite adverse
neonatal outcome. This was done using
generalized additive logistic regression
models in which the effect of gestational
age is estimated with a smoothed curve.22
We tested for differences between the 2
groups using likelihood ratio tests.
RESULTS
In the DIGITAT trial, 321 women were
randomized for induction and 329 for an
TABLE 2
Distribution of MAIN score, frequen
Morbidity or MAIN score item












Serum bilirubin 251-340 mol/L or photo
..........................................................................................................
Apnea and need for oxygenb
..........................................................................................................
Assisted ventilation beyond 24 hb
..........................................................................................................
Cord blood pH 7.1
..........................................................................................................
Hypoglycemia (glucose concentration 2.
..........................................................................................................
Intraventricular hemorrhage grade I or II
..........................................................................................................
















Data were analyzed with the Student t test 2 test or Fisher e
CI, confidence interval; CNM, composite neonatal morbidity; M
a P .05; b More than 2 consecutive readings.
Boers. Neonatal morbidity in the disproportionate intrauexpectant management policy (Figure1). The MAIN score was assessed in 308
induction group babies and in 315 ex-
pectant management group babies.
Baseline characteristics and main trial
results are displayed in Table 1. There
were no differences between the ran-
domized groups in maternal comorbidi-
ties such as preeclampsia or gestational
hypertension, heart and vascular disor-
ders, or autoimmune disease (data not
shown).
As a result of deferring delivery for 10
days with expectant management, gesta-
tional age and birthweight differed sig-
nificantly between the 2 groups. More
babies were admitted to the intermediate
level of care after induction. No other
differences at baseline were found.
Most women who were randomized
met either the fetal abdominal circum-
scored/relevant MAIN items, and CN
Induction of labor




259 (84.1) 258 (
.........................................................................................................................
47 (15.3) 51 (
.........................................................................................................................
2 (0.7) 5 (
.........................................................................................................................
0 (0) 1 (
.........................................................................................................................
.........................................................................................................................
apy 32 (10.4) 18 (
.........................................................................................................................
2 (0.7) 5 (
.........................................................................................................................
0 (0.0) 5 (
.........................................................................................................................
11 (3.6) 19 (
.........................................................................................................................
mol/L) 35 (11.4) 34 (
.........................................................................................................................
0 (0) 1 (
.........................................................................................................................
0 (0) 1 (
.........................................................................................................................
.........................................................................................................................
0 (0) 1 (
.........................................................................................................................
0 (0) 0 (
.........................................................................................................................
0 (0) 1 (
.........................................................................................................................
0 (0) 0 (
.........................................................................................................................
0 (0) 0 (
.........................................................................................................................
0 (0) 0 (
.........................................................................................................................
test.
, Morbidity Assessment Index for Newborns; NA, not applicable.
e growth intervention trial at term. Am J Obstet Gynecol 201ference below the 10th centile or the es-
APRIL 2012 Americtimated fetal weight below the 10th cen-
tile criterion (Table 1). Only 13 women
in the induction group and 10 in the ex-
pectantmonitoring groupwere included
because of flattening of the fetal abdom-
inal circumference growth curve only.
The categories of the MAIN scores
(no/minimal, mild, moderate, and se-
vere morbidity) did not differ between
the induction and expectant group.
When we looked at components of the
MAIN score, more children suffered
from hyperbilirubinemia greater than
220 mmol/L or the need for photother-
apy after induction of labor (Table 2). In
Table 2, composite neonatal morbidity
(CNM) is shown. When we stratified for
different admission types (NICU, inter-
mediate level care, ward), we also found
comparable MAIN scores (Table 3).







9) 2.2 (3.7 to 8.1)
..................................................................................................................
2) 0.9 (6.7 to 4.8)
..................................................................................................................
) 0.9 (2.6 to 0.7)
..................................................................................................................





) 0.9 (2.6 to 0.7)
..................................................................................................................
) 1.6 (3.0 to 0.2)
..................................................................................................................
) 2.4 (5.8 to 0.9)
..................................................................................................................
8) 0.6 (4.4 to 5.5)
..................................................................................................................
) 0.3 (0.9 to 0.3)
..................................................................................................................
) 0.3 (0.9 to 0.3)
..................................................................................................................
..................................................................................................................




















































AINStratification for different weight per-





Research Obstetrics www.AJOG.orgcentiles showed no differences between
the MAIN score (Table 3). Five children
were admitted to intensive care with a
MAIN score of zero.
Figure 2 shows the percentage of neo-
natal admissions related to gestational
age at randomization for both groups.
Gestational age had a significant effect
on the risk of being admitted to neonatal
care (NICU and intermediate level care),
with a higher risk at a lower gestational
age. The percentage of children admitted
to neonatal care was lower after an ex-
pectant management.
TABLE 3
Mean MAIN score shown for differe
Admission category Induction
Intensive care n  9 11
..........................................................................................................
Intermediate care n  143
..........................................................................................................
Ward/no admission n  156
..........................................................................................................




Less than p 2.3 n  38 9
..........................................................................................................
p 2.3-p 5 n  79 5
..........................................................................................................
p 5-p 10 n  83 5
..........................................................................................................
p 10-p 75 n  107
..........................................................................................................
Greater than p75 n  10, 0
...................................................................................................................
Table shows mean, median (interquartile range 25th to 75th p
CI, confidence interval; NA, not applicable.





Boers. Neonatal morbidity in the disproportionate
intrauterine growth intervention trial at term. Am J Obstet
Gynecol 2012.344.e5 American Journal of Obstetrics& GynecoloWe also compared the percentage of
babies born after induction of labor with
a positive MAIN score with babies born
after an expectant management. Al-
though we found fewer babies with a
positive MAIN score beyond 38 weeks’
randomization as compared with ran-
domization at 36 or 37 weeks, the per-
centages in the 2 groups were compara-
ble (Figure 3).
In Figure 4, we compared the primary
outcome of the trial (composite adverse
neonatal outcome; perinatal death, arte-
rial umbilical artery pH below 7.05; 5
minute Apgar below 7; or admission to
the NICU) in relation to gestational age
at randomization. In both the induction
group as well as in babies born after ex-
pectant management, at the different
gestational ages, comparable percent-
ages of composite adverse outcome were
found.
For all 3 outcomes (neonatal admis-
sions, positive MAIN score, and com-
posite adverse outcome), we compared
induction vs expectant management in
women randomized before 38 weeks,
from 38 to 40 weeks and after 40 weeks.
The only difference was a higher per-
centage of neonatal admissions after in-
duction before 38 weeks’ gestational age;
125 (61%) admissions vs 92 (44%) after
expectant management, difference, 16%
admission categories and different
labor Expectant monitoring
36 (0–151) n  10 363, 203 (101–
.........................................................................................................................
0 (0–151) n  111 104, 98 (0–15
.........................................................................................................................
(0–0) n  194 6, 0 (0–0)
.........................................................................................................................
0 (0–0) n  315 52, 0 (0–0)
.........................................................................................................................
.........................................................................................................................
(0–151) n  93 85, 0 (0–151)
.........................................................................................................................
(0–103) n  74 39, 0 (0–0)
.........................................................................................................................
(0–0) n  60 39, 0 (0–0)
.........................................................................................................................
0 (0–0) n  86 34, 0 (0–0)
.........................................................................................................................
1) n  0 NA
.........................................................................................................................
ntile). Data were analyzed with the Student t test.
e growth intervention trial at term. Am J Obstet Gynecol 201(95% CI, 6.7–26%; P .001).
gy APRIL 2012COMMENT
This study confirmed findings of the
DIGITAT, inwhich no significant differ-
ences in neonatal morbidity between
induction and expectant management
were found. This supports the hypothe-
sis that the higher rate of admissions af-
ter induction of labor was a regular care-
driven effect of a lower gestational age
and lower birthweight, rather than be-
cause of defined complications.
Our study was limited to babies sus-




of neonates with an adverse
composite outcome
oers. Neonatal morbidity in the disproportionate





) n  19 –244 (–520 to 31)
..................................................................................................................
n  254 19.26 (49 to 17)
..................................................................................................................
n  350 4 (8–1)
..................................................................................................................
n  623 6 (24 to 12)
..................................................................................................................
..................................................................................................................
n  131 5 (45 to 55)
..................................................................................................................
n  153 11 (18 to 40)
..................................................................................................................
n  143 11 (28 to 52)
..................................................................................................................














































































































www.AJOG.org Obstetrics Researchwhich is when most IUGR is detected.23
In the DIGITAT, approximately 70% of
children in fact had a birthweight below
the 10th centile, with a higher percentage
of very low birthweight (less than P2.3)
after expectant management. Appar-
ently the group of patients with sus-
pected growth restriction is mixed, with
some babies who are really growth re-
stricted in which normal physiological
growth is inhibited and others who are
small for gestational age but grow along
their own growth trajectory. The expect-
antmanagementmakes the contribution
of those who stopped growing more
prominent.
The mean MAIN scores reported in
the present study (49) were lower than
those published by Verma et al21 (235).
he neonates in our study showed no
r minimal morbidity, whereas the
core of Verma et al indicated mild
orbidity for neonates with an IUGR.
ne explanation is that we limited our
tudy to pregnancies beyond 36 weeks,
hereas Verma et al included neonates
rom 28 weeks onward. Another expla-
ation might be that we used discharge
ummaries, whereas Verma et al used
ull hospital records to calculate the
AIN score. Finally, the growth re-




of neonates with a positive
MAIN score
MAIN, Morbidity Assessment Index for Newborns.
Boers. Neonatal morbidity in the disproportionate
intrauterine growth intervention trial at term. Am J Obstet
Gynecol 2012.ere than the patients included in thetudy of Verma et al, which defined
UGR as a birthweight below the third
entile.
The fact that 5 children admitted to
he intensive care unit had aMAIN score
f zero supports the hypothesis that
ometimes admission to intensive care
as related to only gestational age or
irthweight rather than morbidity. Even
hough admission to the NICU implies
erious morbidity, these children were
dmitted mainly for neonatal observa-
ion. For example, 1 child in the expect-
nt management group was admitted to
he NICU with a birthweight of 1670 g
ut no serious morbidity.
During the trial, the IUGR pregnan-
ies were closely monitored, and there-
ore, we cannot exclude that pregnant
omen and their babies received more
han usual attention because of the set-
ing of the study. The results should not
e extrapolated to settings in which such
onitoring cannot be provided. This
onitoring also might explain why our
orbidity as defined by the MAIN score
as relatively mild.
The observation that more babies in
he induction group had hyperbiliru-
inemia is probably explained by being
orn at an earlier gestational age follow-
ng an induction policy.24
The lack of effect of the induction policy
on hypoglycemia, which might have been
expected in relatively premature, growth-
restricted babies might be explained by
some neonates born after expectant man-
agement getting more severely growth re-
stricted and undernourished, also leading
to hypoglycemia. In general, in the expect-
ant management group, there was no ex-
clusive neonatal complication that con-
tributed to the MAIN score. However,
although not statistically significant, more
children were having respiratory prob-
lems, which means different and possibly
more serious morbidity during expectant
monitoring. Two of these children were
born with a birthweight above the 10th
percentile, which reminds us of the chal-
lenges of defining true growth restriction
prenatally.
Children born with a low birthweight
are prone to develop diseases in later life,
and associationswithmetabolic syndrome
in adolescence and adult life have been
APRIL 2012 Americstudied extensively.4 However, the conse-
uencesof lateprematuritywith lowbirth-
eight, comparedwith longer exposure to
n undernourished intrauterine environ-
ent, on neurocognitive and physical de-
elopment needs to be studied in detail
hrough future follow-up studies.
We found that neonatal admissions
ere lower after expectant management
or those who were randomized before
8 weeks’ gestational age, whereas the
eonatal admission rates were compara-
le between both groups after 38 weeks.
his suggests that if induction is contem-
lated, the optimal time to do it is
round 38 weeks’ gestational age.
However, in general, in pregnancies
ith IUGR, there is an increased risk of
tillbirth, with an even higher risk in chil-
ren with a birthweight below the third
ercentile,6,17 and we found a higher per-
entageof these very lowbirthweights after
xpectant monitoring.18Therefore, in the
resence of other pathological findings,
uch as abnormal Doppler measurements
r abnormalities in fetal surveillance, in-
uctionmaybe implemented at lower ges-
ational ages.
In conclusion, the apparent excess of
eonatal care admission in the induction
rm of the DIGITAT trial is probably a
enign side effect of late prematurity and
eonatal admission policies, rather than
marker of serious neonatal morbidity.
his means that those who believe for
ther reasons that induction may pre-
mpt late stillbirths in this group can be
eassured that such a policy does not ap-
ear to increase short-term neonatal
orbidity.
If a policy of induction for near-term
rowth restriction is to be followed, de-
erring induction until 38 weeks, whereas
trictly monitoring the mother and child
ay prevent complications of late prema-
urity. Late effects of these policies need
urther study. f
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